基本信息
views: 2
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Ho’s clinical and research interests include dermatologic therapeutics and oncology, and brings his experience in pharmacology to his research and patients. He has conducted over 60 studies since 1989, and has published extensively: over 80 journal publications, 60 papers presented at conferences, and 11 chapters co-authored in textbooks. As part of his work at the BC Cancer Agency, Dr. Ho is closely involved in cancer prevention campaigns such as the “‘Sun Awareness Week” and “Mole Patrol”.
Research Interests
Papers共 698 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Acta oncologica (Stockholm, Sweden) (2024): 28-34
Transplantation and cellular therapyno. 7 (2024): 687.e1-687.e13
Corey Cutler,Haesook T Kim,Hassan El Banna, Elizabeth Halloran, Emily Matozel,Vincent Ho,John Koreth,Mahasweta Gooptu,Roman M. Shapiro,Amar H. Kelkar, Chris J. Gibson,Carol Reynolds,
Transplantation and Cellular Therapyno. 2 (2024): S26-S27
Vincent K. Y. Ho, Charlotte L. Deijen, Birgit Hemmes,Felice N. van Erning,Petur Snaebjornsson,Baukelien van Triest,Brechtje A. Grotenhuis
INTERNATIONAL JOURNAL OF CANCERno. 9 (2024): 1569-1578
BLOOD ADVANCESno. 3 (2024): 667-680
Roman M Shapiro,Haesook T Kim,Remy Dulery,Deborah Liney,Heather M Garrity, Kevin M Panaro, Chloe Au, Casey Gervais,Jessica S Little,Vincent T Ho,Corey S Cutler,John Koreth,
Blood advances (2024)
Frontiers in immunology (2024): 1359113-1359113
Transplantation and Cellular Therapy (2024)
Blood advancesno. 4 (2024): 978-990
Load More
Author Statistics
#Papers: 683
#Citation: 31493
H-Index: 95
G-Index: 161
Sociability: 8
Diversity: 0
Activity: 6
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn